Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 51-60 of 125 for Ovarian

Edit search filters
  1. Pembrolizumab With Chemotherapy And With/Without MK-4830 For Treating Participants With Ovarian Cancer

    Jacksonville, FL

  2. A First-in-Human Study Of MEN2501 In Participants With Platinum-Resistant Ovarian Cancer

    Rochester, MN

  3. Olaparib Monotherapy In Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.

    Rochester, MN

  4. MV-NIS Infected Mesenchymal Stem Cells In Treating Patients With Recurrent Ovarian Cancer

    Rochester, MN

  5. OTL38 For Intra-operative Imaging Of Folate Receptor Positive Ovarian Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  6. Study Of The Safety, Pharmacokinetics And Efficacy Of EDO-S101, In Patients With Advanced Solid Tumors

    Scottsdale/Phoenix, AZ, Rochester, MN

  7. A Study Of Niraparib In Patients With Ovarian Cancer Who Have Received Three Or Four Previous Chemotherapy Regimens

    Rochester, MN

  8. Ribociclib And Letrozole In Treating Patients With Relapsed ER Positive Ovarian, Fallopian Tube, Primary Peritoneal, Or Endometrial Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  9. A Study Of The Effectiveness And Safety Of Pembrolizumab (MK-3475) For Women With Advanced Recurrent Ovarian Cancer

    Rochester, MN

  10. Folate Receptor Alpha Peptide Vaccine With GM-CSF Versus GM-CSF Alone In Patients With Platinum Sensitive Ovarian Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer